Georg Varga Selected Research

Contact Dermatitis (Eczema, Contact)

7/2004

Enhanced contact hypersensitivity and antiviral immune responses in vivo by keratinocyte-targeted overexpression of IL-15.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Georg Varga Research Topics

Disease

12	Inflammation (Inflammations) 01/2021 - 07/2003
5	Crohn Disease (Crohn's Disease) 01/2021 - 03/2015
5	Infections 01/2018 - 10/2007
3	Arthritis (Polyarthritis) 01/2021 - 01/2016
3	Ulcerative Colitis 01/2021 - 07/2020
2	Neoplasms (Cancer) 01/2022 - 03/2015
2	Hypersensitivity (Allergy) 08/2014 - 01/2002
2	Atherosclerosis 07/2013 - 01/2013
2	Lymphopenia (Lymphocytopenia) 07/2013 - 01/2013
2	Skin Diseases (Skin Disease) 01/2006 - 12/2003
1	Psoriatic Arthritis 01/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2020
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2016
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2016
1	Necrosis 01/2016
1	Simian Acquired Immunodeficiency Syndrome 11/2015
1	Colitis 07/2015
1	Autoimmune Diseases (Autoimmune Disease) 08/2014
1	Endotoxemia 06/2013
1	Sepsis (Septicemia) 06/2013
1	Primary Immunodeficiency Diseases 01/2012
1	Leishmaniasis 09/2008
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2005
1	Contact Dermatitis (Eczema, Contact) 07/2004
1	Lethargy 11/2003
1	Glomerulonephritis 07/2003
1	Allergic Contact Dermatitis 01/2002
1	Irritant Dermatitis 01/2002

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 01/2022 - 04/2010
3	Janus KinasesIBA 01/2021 - 07/2020
3	tofacitinibIBA 01/2021 - 07/2020
3	AlarminsIBA 01/2020 - 06/2013
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2016 - 03/2015
3	IntegrinsIBA 01/2012 - 01/2002
2	LigandsIBA 06/2013 - 09/2008
1	Peptides (Polypeptides)IBA 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	MyokinesIBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	MyostatinIBA 01/2021
1	Janus Kinase InhibitorsIBA 07/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018
1	Doxycycline (Periostat)FDA LinkGeneric 11/2016
1	Cathepsin BIBA 01/2016
1	Pathogen-Associated Molecular Pattern MoleculesIBA 11/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2015
1	Therapeutic UsesIBA 07/2015
1	Dextran SulfateIBA 07/2015
1	Biomarkers (Surrogate Marker)IBA 03/2015
1	Phosphotransferases (Kinase)IBA 10/2014
1	GlucocorticoidsIBA 08/2014
1	ChemokinesIBA 04/2014
1	InterferonsIBA 07/2013
1	oxidized low density lipoproteinIBA 07/2013
1	Interleukin-2 (IL2)IBA 07/2013
1	Sphingosine-1-Phosphate ReceptorsIBA 07/2013
1	Fingolimod Hydrochloride (FTY720)FDA Link 07/2013
1	KRP-203IBA 07/2013
1	S100A12 ProteinIBA 06/2013
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2013
1	LDL Receptors (LDL Receptor)IBA 01/2013
1	LyasesIBA 01/2013
1	LipopolysaccharidesIBA 10/2009
1	polyacrylamideIBA 10/2009
1	Lymphotoxin-alpha (Lymphotoxin)IBA 09/2008
1	Calcitriol Receptors (Calcitriol Receptor)IBA 10/2007
1	pimecrolimus (Elidel)FDA Link 01/2006
1	Calcineurin InhibitorsIBA 01/2006
1	SteroidsIBA 01/2006
1	VaccinesIBA 01/2005
1	DermaVirIBA 01/2005
1	Interleukin-15 (Interleukin 15)IBA 07/2004
1	Antiviral Agents (Antivirals)IBA 07/2004
1	Keratin-14 (Keratin 14)IBA 07/2004
1	BiglycanIBA 07/2003
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2003
1	Messenger RNA (mRNA)IBA 07/2003
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 07/2003
1	CD18 AntigensIBA 01/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2018
1	Therapeutics 08/2014
1	Subcutaneous Injections 10/2009
1	Intravenous Injections 11/2003